iSpecimen (ISPC) Competitors $1.24 -0.09 (-6.44%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.26 +0.03 (+2.43%) As of 04/17/2025 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ISPC vs. PMAX, IDW, XYLO, ATXG, BAOS, TNMG, FTFT, STAF, SOPA, and DKDCAShould you be buying iSpecimen stock or one of its competitors? The main competitors of iSpecimen include Powell Max (PMAX), IDW Media (IDW), Xylo Technologies (XYLO), Addentax Group (ATXG), Baosheng Media Group (BAOS), TNL Mediagene - Ordinary Shares (TNMG), Future FinTech Group (FTFT), Staffing 360 Solutions (STAF), Society Pass (SOPA), and Data Knights Acquisition (DKDCA). These companies are all part of the "business services" industry. iSpecimen vs. Powell Max IDW Media Xylo Technologies Addentax Group Baosheng Media Group TNL Mediagene - Ordinary Shares Future FinTech Group Staffing 360 Solutions Society Pass Data Knights Acquisition iSpecimen (NASDAQ:ISPC) and Powell Max (NASDAQ:PMAX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings. Does the MarketBeat Community favor ISPC or PMAX? iSpecimen received 3 more outperform votes than Powell Max when rated by MarketBeat users. CompanyUnderperformOutperformiSpecimenOutperform Votes375.00% Underperform Votes125.00% Powell MaxN/AN/A Do institutionals & insiders have more ownership in ISPC or PMAX? 13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is ISPC or PMAX more profitable? Powell Max has a net margin of 0.00% compared to iSpecimen's net margin of -91.66%. Powell Max's return on equity of 0.00% beat iSpecimen's return on equity.Company Net Margins Return on Equity Return on Assets iSpecimen-91.66% -139.25% -73.97% Powell Max N/A N/A N/A Which has higher earnings & valuation, ISPC or PMAX? Powell Max has higher revenue and earnings than iSpecimen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiSpecimen$9.29M0.33-$11.10M-$18.58-0.07Powell Max$46.62M0.10N/AN/AN/A Does the media favor ISPC or PMAX? In the previous week, iSpecimen had 2 more articles in the media than Powell Max. MarketBeat recorded 2 mentions for iSpecimen and 0 mentions for Powell Max. Powell Max's average media sentiment score of 0.00 beat iSpecimen's score of -1.00 indicating that Powell Max is being referred to more favorably in the news media. Company Overall Sentiment iSpecimen Negative Powell Max Neutral SummaryiSpecimen and Powell Max tied by winning 5 of the 10 factors compared between the two stocks. Get iSpecimen News Delivered to You Automatically Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ISPC vs. The Competition Export to ExcelMetriciSpecimenCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.08M$3.02B$5.31B$7.35BDividend YieldN/A2.66%5.45%4.34%P/E Ratio-0.0689.8921.9417.82Price / Sales0.33122.94380.6697.73Price / CashN/A34.5738.2534.64Price / Book0.062.286.453.98Net Income-$11.10M$118.81M$3.22B$247.81M7 Day Performance-2.76%-4.08%0.74%0.28%1 Month Performance-9.85%-13.98%-9.66%-7.60%1 Year Performance328.37%-17.73%11.81%1.49% iSpecimen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ISPCiSpecimen0.8364 of 5 stars$1.24-6.4%N/A+328.4%$3.08M$9.29M-0.0660Earnings ReportShort Interest ↓Gap DownPMAXPowell MaxN/A$0.33-3.0%N/AN/A$4.72M$46.62M0.00N/AGap DownIDWIDW MediaN/A$0.33flatN/AN/A$4.48M$30.84M-0.9480Negative NewsXYLOXylo Technologies0.4138 of 5 stars$5.27+3.3%N/AN/A$4.31M$57.64M0.0030Upcoming EarningsHigh Trading VolumeATXGAddentax Group0.5087 of 5 stars$0.64-5.9%N/A-31.4%$3.87M$4.55M-2.29130BAOSBaosheng Media Group0.3218 of 5 stars$2.12-13.1%N/A-46.7%$3.73M$859,226.000.00130Positive NewsGap DownTNMGTNL Mediagene - Ordinary SharesN/A$0.49-18.3%N/AN/A$3.23M$47.43M0.00N/AFTFTFuture FinTech Group1.1937 of 5 stars$1.42+7.6%N/A-84.1%$2.95M$18.54M0.0070STAFStaffing 360 SolutionsN/A$1.62flatN/AN/A$2.66M$190.88M0.00200SOPASociety Pass2.3257 of 5 stars$0.71-5.0%$16.00+2,153.2%-57.1%$2.59M$6.91M-0.142,021Earnings ReportUpcoming EarningsShort Interest ↑Negative NewsDKDCAData Knights AcquisitionN/A$0.45-15.1%N/A-25.3%$2.33MN/A-2.372High Trading Volume Related Companies and Tools Related Companies PMAX Competitors IDW Competitors XYLO Competitors ATXG Competitors BAOS Competitors TNMG Competitors FTFT Competitors STAF Competitors SOPA Competitors DKDCA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ISPC) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
